Latest Enorama Pharma News & Updates

See the latest news and media coverage for Enorama Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Enorama Pharma

Swedish pharmaceutical company developing oral nicotine products

enoramapharma.com

Headquarters: Malmö, Sweden
Founded year: 2006
Company type: Public company
Number of employees: 5–10

Last updated Today

Latest news about Enorama Pharma

In short: Enorama Pharma faced financial distress after an FDA rejection, resulting in a balance sheet crisis, leadership changes, and asset divestments.

Company announcements

May 20 Enorama Pharma

Enorama Pharma divests the nicotine gum business to Aflofarm

The purchase price is 100,000 EUR. The deal includes marketing authorizations and patents.

May 13 Enorama Pharma

Enorama Pharma calls for annual general meeting on June 16, 2026

The meeting is held in Malmö and deals with election of board, fees and authorization for new issue.

April 24 Enorama Pharma

Enorama Pharma publishes annual report and auditor's report for 2025

The documents can be downloaded from the company's website or via pdf in the press release.

April 7 Enorama Pharma

Enorama Pharma holds extraordinary general meeting

The meeting decides to continue the operations and avoid liquidation. The board hopes for capital injection within 8 months.

Media coverage

March 11 Dagens industri

Enorama calls for extraordinary meeting - to decide whether the company should continue operations

Close Agenda: Rusta, Zalando and definitive KPI. Thursday's highlights with Noel Hermansson The equity in Enorama Pharma, a company active in tobacco-free white snus, is below...

March 3 Placera.se

Enorama Pharma AB (publ) announces board and management changes | Placera.se

Enorama Pharma AB (publ) ("Enorama Pharma" or "the Company") announces today an organizational change in the board and management group. The board has, in agreement with managing director Daniel Schröder...

February 19 Tobacco Reporter

Enorama Sues FDA for Disparate Pouch PMTAs - Tobacco Reporter

Enorama Pharma Inc. filed a lawsuit against the U.S. Food and Drug Administration in federal court in Washington, D.C., alleging the agency unlawfully imposed costly...

February 13 Dagens industri

Enorama Pharma prepares control balance sheet

The board of directors in Enorama Pharma, active in tobacco-free white snus, has decided to prepare a control balance sheet.

Never miss news about Enorama Pharma

Track Enorama Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Enorama Pharma competitors & trending companies

Browse news for competitors to Enorama Pharma and other trending companies.